bioRxivMicrobiologyPreprint
Engineered reporter phages for rapid detection of Escherichia coli, Klebsiella spp., and Enterococcus spp. in urine
S. Meile, J. Du, S. Staubli, S. Grossmann, H. Koliwer-Brandl, P. Piffaretti, L. Leitner, C. I. Matter, J. Baggenstos, L. Hunold, S. Milek, C. Guebeli, M. Kozomara-Hocke, V. Neumeier, A. Botteon, J. Klumpp, J. Marschall, S. McCallin, R. Zbinden, T. M. Kessler, M. J. Loessner, M. Dunne, S. Kilcher
Abstract
The rapid detection and species-level differentiation of bacterial pathogens facilitates antibiotic stewardship and improves disease management. Here, we develop a rapid bacteriophage-based diagnostic assay to detect the most prevalent pathogens causing urinary tract infections: Escherichia coli, Klebsiella spp., and Enterococcus spp. For each uropathogen, two virulent phages were genetically engineered to express a nanoluciferase reporter gene upon host infection. Using 206 patient urine samples, reporter phage-induced bioluminescence was quantified to identify bacteriuria and the assay was benchmarked against conventional urinalysis. Overall, E. coli, Klebsiella spp., and Enterococcus spp. were each detected with high sensitivity (68%, 78%, 85%), specificity (99%, 99%, 99%), and accuracy (90%, 94%, 96%) at a resolution of [>=]103 CFU/ml within 5 h. We further demonstrate how bioluminescence in urine can be used to predict phage antibacterial activity, demonstrating the future potential of reporter phages as companion diagnostics that guide patient-phage matching prior to therapeutic phage application.
- organism: E. coli
- organism: mouse
- organism: human
- assay: metagenomics
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery and characterisation of new phage targeting uropathogenic Escherichia coli
S. A. Kangachar, D. Y. Logel, … P. R. Jaschke·VirologyPeer-reviewed·Sep 1, 2024
- Genomic and phenotype-based framework for rational design of phage cocktails against Escherichia coli isolates from urinary tract infections
Paul Ugalde‐Silva, Ally Champoux, … Louis‐Charles Fortier·bioRxiv·Sep 25, 2026
- Sensitive detection of Live Escherichia coli by bacteriophage amplification-coupled immunoassay on the Luminex(R) MAGPIX instrument
T. Mido, E. M. Schaffer, … E. R. Hofmann·bioRxiv·May 9, 2018
- Analysis of selection methods to develop novel phage therapy cocktails against antimicrobial resistant clinical isolates of bacteria
M. E. Haines, F. E. Hodges, … M. R. Clokie·bioRxiv·Oct 13, 2020
- Lytic bacteriophages active in urine against multi-drug resistant clinically derived Klebsiella pneumoniae causing urinary tract infection
Ruxandra Câlin, Blanca Bernabeu Vilaplana, … Régis Tournebize·International Journal of Infectious DiseasesPeer-reviewed·Jul 5, 2026
- Quorum sensing and capsule expression enable subpopulation evasion of phage killing in Escherichia coli ST131: Implications for targeted therapy
Alba Park de la Torriente, Talal hossain, … David L. Gally·bioRxiv·Apr 8, 2026